吉田修
Habuchi T, Kinoshita H, Yamada H, Kakehi Y, Ogawa O, Wu WJ, Takahashi R, Sugiyama T, Yoshida O.
Oncogene amplification in urothelial cancers with p53 gene mutation or MDM2 amplification.
J Natl Cancer Inst. 1994 Sep 7;86(17):1331-5.
Okuno H, Kakehi Y, Ozdemir E, Terachi T, Okada Y, Yoshida O.
Association of in vitro growth potential of urinary exfoliated cells with tumor localization and intraluminal recurrence rates of urothelial cancers.
J Urol. 1997 Nov;158(5):1996-9.
Habuchi T, Yoshida O, Knowles MA.
A novel candidate tumour suppressor locus at 9q32-33 in bladder cancer: localization of the candidate region within a single 840 kb YAC.
Hum Mol Genet. 1997 Jun;6(6):913-9.
Kinoshita H, Ogawa O, Kakehi Y, Mishina M, Mitsumori K, Itoh N, Yamada H, Terachi T, Yoshida O.
膀胱(尿路上皮)がんの研究
Miyakawa M, Yoshida O.
DNA synthesis of the urinary bladder epithelium in rats with long-term feeding of dl-tryptophan-added and pyridoxine-deficient diet.
Gann. 1973 Aug;64(4):411-3.
Miyakawa M, Yoshida O.
Protective effects of DL-tryptophan on benzidine-induced hepatic tumor in mice.
Gann. 1980 Apr;71(2):265-8.
Fujita J, Yoshida O, Yuasa Y, Rhim JS, Hatanaka M, Aaronson SA.
Ha-ras oncogenes are activated by somatic alterations in human urinary tract tumours.
Nature. 1984 May 31-Jun 6;309(5967):464-6.
Fujita J, Ohuchi N, Ito N, Reynolds SH, Yoshida O, Nakayama H, Kitamura Y.
Activation of H-ras oncogene in rat bladder tumors induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.
J Natl Cancer Inst.